Spain· ES:60113
IMUKIN 100 microgramos SOLUCION INYECTABLE
A interferon gamma-1b product containing interferon gamma-1b, registered in Spain by Clinigen Healthcare B.V.. The same ATC class is registered in 3 of our 19 countries.
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
Where it is registered
Interferon gamma-1b is registered in 3 of 19 countries.
Countries holding a registration under ATC L03AB18 (interferon gamma-1b), each read from that country’s own register.
- This record: Spain, from AEMPS CIMA (Spain)
- 3 of them publish a price we can compare per daily dose
Interferon gamma-1b · ATC L03AB18
3 / 19 countries
- Franceprice
- Spainprice
- United Statesprice
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- interferon gamma-1b
- Manufacturer
- Clinigen Healthcare B.V.
- Country
- Spain (ES)
- ATC code
- L03AB18
- ATC class
- Interferon gamma-1b
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cima_codigo6961611EUR 122.55
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
80 interactions on record for interferon gamma-1b.
Graded by severity as the source publishes them — 27 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Interferon gamma-1b · interactions on record
80 records
- 27 severe
- 53 moderate
Most severe, free to view
- CladribineL01BB04severe
- BexaroteneL01XF03severe
- BexarotenL01XX25severe
- LeflunomidL04AA13severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Interferon gamma-1b in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumImmukine 0,10 mgHorizon Pharma Ireland
- NorwayImukinClinigen
- United StatesACTIMMUNEHorizon Therapeutics USA, Inc.
- FinlandImukinBoehringer Ingelheim International GmbH
- NetherlandsIMMUKINE, oplossing voor injectie 2 x 10.6 IE (0,1 mg)Clinigen Healthcare B.V.
- FranceIMUKIN 2 x 10<sup>6</sup> UI (0,1 mg), solution injectableCLINIGEN HEALTHCARE (PAYS BAS)
- GermanyImukinClinigen Healthcare B.V.
Authorised across Europe · EMA
The same active substance is authorised in 5 EEA countries. Names it is sold under:
- Germany · Imukin
- France · Imukin
- United Kingdom (Northern Ireland) · Immukin
- Italy · Imukin
- Netherlands · Immukine
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d8260adf-db2f-4da6-a7df-35fbb7440dfe GET /v1/drugs/d8260adf-db2f-4da6-a7df-35fbb7440dfe?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Diagnóstico Hospitalario",
"estado": "{\"aut\":770421600000}",
"nregistro": "60113",
"substance": "interferon gamma-1b"
}See everything about interferon gamma-1b.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.